Antimicrobial resistance of uropathogens among outpatients, 2000-2004;Resistência antimicrobiana dos uropatógenos em pacientes ambulatoriais, 2000-2004

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 3, 2008, Pages 277-281

  Koch, Camila Ribeiro ^a   Ribeiro, Juliana Camurça ^a   Schnor, Otávio Haygert ^a   Zimmermann, Bruno Sudbrack ^a   Müller, Fernanda Melo ^a   D'Agostin, Juliana ^a   Machado, Vívian ^a   Zhang, Linjie ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b Depto Materno Infantil/FURG   (Brazil)

Author keywords

Antibiotics; Bacterial resistance; Retrospective study; Urinary tract infection; Urine culture

Indexed keywords

CEFALOTIN; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; NITROFURANTOIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATHOGENESIS; PROTEUS MIRABILIS; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIA; HOSPITALS, UNIVERSITY; HUMANS; KLEBSIELLA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PROTEUS MIRABILIS; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS; YOUNG ADULT;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA; PROTEUS MIRABILIS;

EID: 50149084665     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000300010     Document Type: Article

References (17)

1. Alós JI, Serrano MG, Gómez-Garcés JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clinical Microbiology and Infection 11: 199-203, 2005.
2. Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari AC, Gales AC. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Memórias do Instituto Oswaldo Cruz 101: 741-748, 2006
3. Camargo CBS, Pedro CC, Lourenço DS, Gironi RHAR, Martinez R. Infecçäo de vias urinárias na comunidade de Ribeiräo Preto, SP: etiologia, sensibilidade bacteriana a antimicrobianos e implicaçöes terapêuticas. Medicina (Ribeirão Preto) 35: 173-178, 2002.
4. Erb A, Stürmer T, Marre R, Brenner H. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. European Journal of Clinical Microbiology & Infectious Diseases 26: 83-90, 2007.
5. Gales AC, Sader HS, Jones RN, SENTRY Participants Group (Latin America). Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diagnostic Microbiology and Infectious Diseases 44: 289-299, 2002.
6. Grude N, Tveten Y, Jenkins A, Kristiansen BE. Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment. Scandinavian Journal of Primary health Care 23: 115-119; 2005.
7. herlberg IP, Schor N. Aborgagem Diagnóstica e Terapêutica na Infecção do Trato Urinário -ITU. Revista Associação Médica Brasileira 49: 109-116, 2003.
8. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Journal of Urology 170: 335-336, 2003.
9. Lopes AA, Salgado K, Martinelli R, Rocha H. Aumento da freqüência de resistência à norfloxacina e ciprofloxacina em bactérias isoladas em uroculturas. Revista da Sociedade Médica Brasileira 44: 196-200 1998.
10. McNulty CA, Richards J, Livermore DM, Little P, Charlett A, Freeman E, Harvey I, Thomas M. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. Journal of Antimicrobial Chemotherapy 58: 1000-1008, 2006.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. NCCLS Document M2-A7. Wayne, PA, USA, 2000.
12. National Committee for Clinical Laboratory Standards. Supplemental tables: disk diffusion. NCCLS Document M100-S10. Wayne, PA, USA, 2000.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS Documents M2-A8 and M100-S13. Wayne, PA, USA, 2003.
14. Queiroz K, Poletto RC. Suscetibilidade antimicrobiana de uropatógenos em pacientes ambulatoriais na Cidade de Goiânia, GO. Revista da Sociedade Brasileira de Medicina Tropical 38: 416-420, 2005.
15. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W, Israeli Urinary Tract Infection Group. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX resistant uropathogens. Clinical Infectious Diseases 34: 1165-1169, 2002.
16. Sociedade Brasileira de Urologia. Diretrizes em urologia: Infecção do Trato Urinário. Disponível no site da Sociedade Brasileira de Urologia: http://www.sbu.org.br/socios/diretrizes/ inf_urinaria.pdf, 2004.
17. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in woman. Infectious Diseases Society of America (IDSA). Clinical Infectious Diseases 29: 745-758, 1999.